Overview
| Subspecialty | Cardiology |
|---|---|
| Clinical Interests | Peripheral Vascular Disease |
| Carotid Artery Disease | |
| Hypertension | |
| Thromboembolic Disorders | |
| Vascular Medicine | |
| Languages | English |
| Gender | Male |
| jeffrey.olin@mssm.edu | |
| Education and Training | DO, University of Kansas |
| Residency, Internal Medicine, Cleveland Clinic Foundation | |
| Fellowship, Nephrology, Cleveland Clinic Foundation | |
| Awards | Associate Editor Vascular Medicine |
| 2008 Master of the Society for Vascular Medicine Dr. Olin's only the fourth person to receive this award. |
|
| 2005 - 2007 Chair Interdisciplinary Working Group on Atherosclerotic Peripheral Vascular Disease of the American Heart Association |
|
| 2002 - Present Peripheral Vascular Disease Steering Committee of the American Heart Association |
|
| 2000 - 2005 Scientific Program Committee American College of Cardiology |
|
| 1991 Fellow Society of Vascular Medicine and Biology |
|
| 1991 Fellow American College of Cardiology |
|
| 1990 - 2001 President Society for Vascular Medicine and Biology |
|
| 1987 Fellow American College of Physicians |
|
| 1983 - 1984 Outstanding Teacher Award Department of Medicine the Western Pennsylvania Hospital |
Dr. Olin is a Professor of Medicine at Mount Sinai School of Medicine and Director of Vascular Medicine and the Vascular Diagnostic Laboratory in the Zena and Michael A. Wiener Cardiovascular Institute of The Mount Sinai Medical Center. Dr. Olin has extensive experience in clinical trials including peripheral arterial disease using various pharmacotherapies, as well as immune modulation, and therapeutic angiogenesis. His clinical expertise involves noncoronary vascular disease including peripheral arterial disease, carotid artery disease, renal artery disease and venous thromboembolic disease. He is active in the noninvasive vascular laboratory and has developed new noninvasive techniques to evaluate patients for renal artery stenosis.
Dr. Olin is a past president of the Society for Vascular Medicine and Biology. He is an Associate Editor for the journal Vascular Medicine and the Editor of the textbook Peripheral Vascular Diseases. He serves on the steering committee for the American Heart Association's initiative in peripheral vascular disease as well as the peripheral vascular disease committee of the American College of Cardiology. He currently serves on the annual scientific program committee for the American College of Cardiology.
Dr Olin is an internationally recognized expert in the area of Vascular Medicine. He has held numerous leadership positions and has been at the forefront of establishing Vascular Medicine as a distinct subspecialty of Cardiovascular Medicine. He was instrumental in the formation of the American Board of Vascular Medicine, the first ever board examination in this specialty. Dr. Olin has been in leadership roles in numerous societies and organizations. He is a past president of the Society for Vascular Medicine and Biology and past member of the peripheral vascular disease committee of the American College of Cardiology. He currently chairs the Interdisciplinary Working Group on Atherosclerotic Peripheral Vascular Disease of the American Heart Association and sits on the highest-ranking scientific committee of the American Heart Association, the Scientific Advisory and Coordinating Committee. He is a member of the Board of Directors of the American Board of Vascular Medicine and is one of four physicians selected to direct a task force for the Accreditation of Physicians in Vascular Ultrasound.
Dr. Olin has been involved in clinical research involving peripheral arterial disease, renal artery disease, carotid artery disease and has helped to develop new techniques to nonivasively diagnose renal artery stenosis and to nonsurgically treat patients who develop post catheterization pseudoaneurysms. He along with Dr. John Cooke at Stanford University is conducting the largest NIH study on the Genetics of Peripheral Arterial Disease. He is also the Mount Sinai Principle Investigator of the NIH sponsored CORAL trial studying the effect of stents in patients with atherosclerotic renal artery stenosis. In addition, Dr. Olin was the international Principle Investigator and Chair of the Steering Committee for a study of Immune Modulation Therapy for patients with Peripheral Arterial Disease. He is the current U.S. Principle Investigator for the WALK trial investigating the role of gene therapy to grow new blood vessels in patients with peripheral arterial disease and has been active in gene therapy trials to prevent amputation in those patients with circulatory problems of the legs.
Dr. Olin has authored more than 160 scientific papers in the peer review literature, 3 books and more than 60 book chapters. He has served on many writing committees of the American College of Cardiology and American Heart Association. He currently is Chairing the writing committee on Performance Measures in Peripheral Arterial Disease. He has published in the New England Journal of Medicine, Circulation, Journal of the American Medical Association, Journal of the American College of Cardiology, Journal of Vascular Surgery and Vascular Medicine just to name a few. He is an Associate Editor of the journal Vascular Medicine and Editor of the textbook Peripheral Vascular Diseases.
After receiving his medical degree from the University of Health Sciences in Kansas City, Missouri, he completed his residency and fellowship at the Cleveland Clinic Foundation. In 2003 he came to the Mount Sinai School of Medicine as Director of Vascular Medicine and Co-director of the Vascular Diagnostic Laboratory where he has developed a comprehensive clinical, educational and research program in Vascular Medicine, the study of vascular diseases outside of the heart.
